(Q33223078)

24 July 2017

1 reference

title

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer? (English)

1 reference

24 July 2017

1 reference

1

Caroline M Moore

1 reference

24 July 2017

4

Mark Emberton

1 reference

24 July 2017

Ivan M Hoh

2

1 reference

24 July 2017

Stephen G Bown

series ordinal

3

1 reference

24 July 2017

publication date

1 October 2005

1 reference

24 July 2017

1 reference

24 July 2017

volume

96

1 reference

24 July 2017

issue

6

1 reference

24 July 2017

page(s)

754-758

1 reference

The patient's dilemma: prostate cancer treatment choices

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

The immunological consequences of photodynamic treatment of cancer, a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Clinical outcomes of photodynamic therapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Experimental evaluation of possible side effects of intra‐operative photodynamic therapy on rabbit blood vessels and nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Targeted photodynamic therapy via receptor mediated delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05709.X

10.1111/J.1464-410X.2005.05709.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference